HIV-1 p24 gag, aa155-321, Recombinant (Group-specific Antigen, p24, Gag Polyprotein, Pr55Gag)
Catalog No : USB-H6005-11A
564.38€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | HIV-1 p24 gag, aa155-321, Recombinant (Group-specific Antigen, p24, Gag Polyprotein, Pr55Gag) | ||
|---|---|---|---|
| Catalog No | USB-H6005-11A | ||
| Supplier’s Catalog No | H6005-11A | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E.coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 21.2 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ~80% (SDS-PAGE). | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 100mM sodium chloride, 0.1mM PMSF, 10% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~80% (SDS-PAGE). | ||
| Description | The HIV1 p24 protein performs highly complex orchestrated tasks during the assembly, budding maturation and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag p24, the major capsid protein of the HIV-1 virion, has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different isolates. Source: Recombinant corresponding to aa155-321 of HIV1-p24 recombinant protein, fused to His-tag at N-terminus, expressed in E.coli. AA Sequence: MGSSHHHHHH SSGLVPRGSH MWVKVVEEKA FSPEVIPMFS ALSEGATPQD LNTMLNTVGG HQAAMQMLKE TINEEAAEWD RLHPVHAGPI APGQMREPRG SDIAGTTSTL QEQIGWMTHN PPIPVGEIYK RWIILGLNKI VRMYSPTSIL DIRQGPKEPF RDYVDRFYKT LRAEQASQEV KNWMTETL Molecular Weight: 21.2kD (188aa) confirmed by MALDI-TOF Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved